|
US6133437A
(en)
|
1997-02-13 |
2000-10-17 |
Apoptogen, Inc. |
Modulation of IAPs for the treatment of proliferative diseases
|
|
US7741298B2
(en)
*
|
1997-06-20 |
2010-06-22 |
New York University |
Method and compositions for inhibiting tumorigenesis
|
|
EP1135135A4
(en)
|
1998-09-18 |
2006-08-09 |
Smithkline Beecham Corp |
CHK1 KINASE INHIBITORS
|
|
US6214986B1
(en)
|
1998-10-07 |
2001-04-10 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of bcl-x expression
|
|
US20030190635A1
(en)
|
2002-02-20 |
2003-10-09 |
Mcswiggen James A. |
RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
|
|
EP1386004A4
(en)
|
2001-04-05 |
2005-02-16 |
Ribozyme Pharm Inc |
MODULATION OF GENE EXPRESSION ASSOCIATED WITH INFLAMMATORY PROLIFERATION AND GROWTH OF NEURITIES BY METHODS INVOLVING NUCLEIC ACID
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
US20040019001A1
(en)
|
2002-02-20 |
2004-01-29 |
Mcswiggen James A. |
RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
|
|
AU2003211576A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Sueharu Horinouchi |
Histone deacetylase inhibitors and process for producing the same
|
|
WO2004017991A1
(en)
|
2002-08-13 |
2004-03-04 |
Cell Center Cologne Gmbh |
Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin’s lymphomas
|
|
US20050008617A1
(en)
|
2002-09-28 |
2005-01-13 |
Massachusetts Institute Of Technology |
Compositions and methods for delivery of short interfering RNA and short hairpin RNA
|
|
US20040077083A1
(en)
*
|
2002-10-17 |
2004-04-22 |
Isis Pharmaceuticals Inc. |
Antisense modulation of histone deacetylase 4 expression
|
|
US20040077084A1
(en)
|
2002-10-17 |
2004-04-22 |
Isis Pharmaceuticals Inc. |
Antisense modulation of histone deacetylase 4 expression
|
|
AU2003295600A1
(en)
|
2002-11-14 |
2004-06-15 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
|
CA2523517C
(en)
|
2003-04-25 |
2013-07-30 |
Dana-Farber Cancer Institute, Inc. |
Bcl2l12 polypeptide activators and inhibitors
|
|
US20050043266A1
(en)
|
2003-07-25 |
2005-02-24 |
Sumedha Jayasena |
Short interfering RNA as an antiviral agent for hepatitis C
|
|
WO2005011598A2
(en)
|
2003-07-31 |
2005-02-10 |
University Of South Florida |
Leukemia treatment method and composition
|
|
EP1653973A1
(en)
|
2003-08-08 |
2006-05-10 |
Novartis AG |
Combinations comprising staurosporines
|
|
MX2007001155A
(es)
|
2004-07-29 |
2007-08-14 |
Creabilis Therapeutics Spa |
Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
|
|
AU2006210994A1
(en)
*
|
2005-02-07 |
2006-08-10 |
Topotarget Uk Limited |
Assays for agents with selective cytotoxicty to HDAC resistant cell lines
|
|
US20080021198A1
(en)
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
|
US8222423B2
(en)
*
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
GB0612542D0
(en)
|
2006-06-23 |
2006-08-02 |
Novartis Ag |
Combinations comprising staurosporines
|
|
AU2007333799A1
(en)
*
|
2006-12-15 |
2008-06-26 |
Novartis Ag |
Heterocycle compounds and methods of use thereof
|
|
US10611818B2
(en)
*
|
2007-09-27 |
2020-04-07 |
Agilent Technologies, Inc. |
MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
EA018618B1
(ru)
*
|
2007-10-01 |
2013-09-30 |
Ликсте Байотекнолоджи, Инк. |
Ингибиторы hdac
|
|
EP2231596A4
(en)
*
|
2007-12-14 |
2012-06-06 |
Univ Georgetown |
INHIBITORS OF HISTONATE ACETYLASE
|
|
US20090274682A1
(en)
|
2008-02-05 |
2009-11-05 |
The Trustees Of Princeton University |
Demethylation and inactivation of protein phosphatase 2a
|
|
CN102307475A
(zh)
|
2009-02-04 |
2012-01-04 |
彼帕科学公司 |
用与生长因子抑制剂组合的parp抑制剂治疗肺癌
|